Profile
| Metric | Value |
|---|---|
| Full Name | Ascentage Pharma Group International |
| Ticker | NASDAQ: AAPG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | China |
| IPO | |
| Indexes | Not included |
| Website | ascentage.cn |
| Employees | 567 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $27.05 | |
| Price, 1D Change | -0.93% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.56 | |
| Revenue | $136M | |
| Revenue, 1Y Change | +334.90% | |
| EPS | -$0.75 | |
| EPS, 1Y Change | +59.70% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | AAPGV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.75 | |
| EPS Estimate | -$1.38 | |
| EPS Est. Change | -85.05% | |
| Revenue | $136.26M | |
| Revenue Estimate | $556.00M | |
| Revenue Est. Change | +308.04% | |
| Current Price | $27.05 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.38 | N/A | - | |
| -$0.48 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $556.00M | N/A | - | |
| $1.82B | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | - | |
| Price, 3Y | - | |
| Market Cap, 1Y | - | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +334.90% | |
| Revenue, 3Y | +3,048.66% | |
| EPS, 1Y | +59.70% | |
| EPS, 3Y | +60.86% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $27.05 | |
| SMA 200 | $32.96 | |
| SMA 200 vs Price | +21.86% | |
| SMA 50 | $30.02 | |
| SMA 50 vs Price | +11.01% | |
| Beta | 0.56 | |
| ATR | $1.06 | |
| 14-Day RSI | 44.63 | |
| 10-Day Volatility | 58.55% | |
| 1-Year Volatility | 62.61% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $136.26M | |
| EPS | -$0.75 | |
| Gross Profit | $132.61M | |
| Gross Margin | 88.39% | |
| Operating Profit | -$51.53M | |
| Operating Margin | -37.70% | |
| Net Income | -$56.37M | |
| Net Margin | -41.34% | |
| EBITDA | -$46.10M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 6.20 | |
| Current Ratio | 1.26 | |
| Quick Ratio | 1.26 | |
| Interest Coverage | -5.13 | |
| - | ||
| Altman Z-Score | 1.76 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 17.81K | |
| PB Ratio | -77.11 | |
| EV/EBITDA | - | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $36.19M | |
| Cash & Equivalents | $172.77M | |
| Total Assets | $359.56M | |
| Current Assets | $201.94M | |
| Total Liabilities | $318.23M | |
| Current Liabilities | $159.81M | |
| Total Debt | $232.60M | |
| Short Term Debt | $106.72M | |
| Accounts Payable | $12.60M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $188.20M | |
| Operating Expenses | $184.14M | |
| Cost Of Goods Sold | $15.82M | |
| SG&A | $53.39M | |
| D&A | $12.98M | |
| Interest Expense | $8.98M | |
| Income Tax | $1.45M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$15.52M | |
| CFI | -$50.46M | |
| CFF | $43.87M | |
| Capex | $3.39M | |
| Free Cash Flow | -$18.90M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Oppenheimer | ||
| Truist Securities | ||
| BTIG | ||
| Piper Sandler | ||
| JP Morgan |
Analyst sentiment
Institutional ownership
Screeners with AAPG
Data Sources & References
- AAPG Official Website www.ascentage.cn
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2023311/000121390025032599/0001213900-25-032599-index.htm
- AAPG Profile on Yahoo Finance finance.yahoo.com/quote/AAPG
- AAPG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aapg
FAQ
What is the ticker symbol for ASCENTAGE PHARMA GROUP INTERNATIONAL?
The ticker symbol for ASCENTAGE PHARMA GROUP INTERNATIONAL is NASDAQ:AAPG
Does ASCENTAGE PHARMA GROUP INTERNATIONAL pay dividends?
No, ASCENTAGE PHARMA GROUP INTERNATIONAL does not pay dividends
What sector is ASCENTAGE PHARMA GROUP INTERNATIONAL in?
ASCENTAGE PHARMA GROUP INTERNATIONAL is in the Healthcare sector
What industry is ASCENTAGE PHARMA GROUP INTERNATIONAL in?
ASCENTAGE PHARMA GROUP INTERNATIONAL is in the Biotechnology industry
What country is ASCENTAGE PHARMA GROUP INTERNATIONAL based in?
ASCENTAGE PHARMA GROUP INTERNATIONAL is headquartered in China
When did ASCENTAGE PHARMA GROUP INTERNATIONAL go public?
ASCENTAGE PHARMA GROUP INTERNATIONAL initial public offering (IPO) was on January 24, 2025
Is ASCENTAGE PHARMA GROUP INTERNATIONAL in the S&P 500?
No, ASCENTAGE PHARMA GROUP INTERNATIONAL is not included in the S&P 500 index
Is ASCENTAGE PHARMA GROUP INTERNATIONAL in the NASDAQ 100?
No, ASCENTAGE PHARMA GROUP INTERNATIONAL is not included in the NASDAQ 100 index
Is ASCENTAGE PHARMA GROUP INTERNATIONAL in the Dow Jones?
No, ASCENTAGE PHARMA GROUP INTERNATIONAL is not included in the Dow Jones index
When was ASCENTAGE PHARMA GROUP INTERNATIONAL last earnings report?
ASCENTAGE PHARMA GROUP INTERNATIONAL's most recent earnings report was on August 20, 2025
When does ASCENTAGE PHARMA GROUP INTERNATIONAL report earnings?
The next expected earnings date for ASCENTAGE PHARMA GROUP INTERNATIONAL is March 26, 2026